Paper Titles
Calcium Phosphates / Biphosphonates Combinations…Towards a Therapeutic Synergy
p.99
Ensuring Implant Fixation and Sol-Gel Derived Ceramic Coatings
p.111
Silica-Based Ordered Mesoporous Materials for Biomedical Applications
p.133
A Genetic Basis for Design of Biomaterials for In Situ Tissue Regeneration
p.151
Cell Proliferation and Tissue Compatibility of Organic-Inorganic Hybrid Materials
p.167
Syntesis of Mesoporous Microparticles for Biomedical Applications
p.181
Rationale of Using Conventional Sol-Gel Derived SiO2 for Delivery of Biologically Active Agents
p.195
A Combined Experimental-Computational Strategy for the Design, Synthesis and Characterization of Bioactive Zinc-Silicate Glasses
p.211
Simulation of Bone Remodelling and Bone Ingrowth within Scaffolds
p.225

Rationale of Using Conventional Sol-Gel Derived SiO2 for Delivery of Biologically Active Agents

Article Preview

Abstract:

Progress in the research of mesoporous materials, hierarchical pore structures, chemical modification of surfaces, nanoparticle processing and hybrid materials is important and it provides new and interesting functional properties for silica structures. However, this has also left the conventional, alkoxy-based sol-gel derived silica in the shadow, although it has a lot of non-utilized potential, especially in the delivery and/or encapsulation of sensitive biologically active agents like viral vectors, proteins, nucleic acids and cells. The potential lies in the versatile possibilities to adjust the structure by using alkoxides as precursors and in the proper use of water in different steps of the processing. The conventional, alkoxy-based sol-gel silica structure can be processed so that it results in largely variable biodegradation rates, biodegradation-controlled release of encapsulated agents and beneficial environment even for highly sensitive agents. These kinds of silica structures contain more or less water and hence, they are more or less labile from the traditional viewpoint of materials science. In extreme case they could be called “unfinished silica”. The aim of this paper is to discuss how the biodegradation rate of these kinds of silica materials can be adjusted on a large scale and how this is related to a rather narrow scale adjustment of in vitro dissolution rate of silica, how the unfinished silica structures can be controlled and their properties adjusted, how they can be utilized in the delivery of biologically active agents, and what the potential problems to be solved are.

You might also be interested in these eBooks
Progress in Bioceramics View Preview

Info:

Periodical:

Key Engineering Materials (Volume 377)

Pages:

195-210

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.377.195

Citation:

Cite this paper

Online since:

March 2008

Authors:

Mika Jokinen, Mika Koskinen, Sami Areva

Keywords:

Alkoxides, Biodegradation, Encapsulation, Hydrogel, In Vitro, In Vivo, Sol-Gel (SG)

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2008 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

References

[1] T. Graham: Journal of the Chemical Society of London Vol. 17 (1864), p.318.

Google Scholar

[2] H. Rupprecht: Pharm. Ind. Vol. 36(4) (1974), p.260.

Google Scholar

[3] H. Rupprecht, K.K. Unger and M. J. Biersack: Coll. Polym. Sci. Vol. 255(3) (1977), p.276.

Google Scholar

[4] K.K. Unger, H. Rupprecht, B. Valentin and W. Kircher: Drug Dev. Ind. Pharm. Vol. 9 (1983), p.69.

Google Scholar

[5] M. L. Lovrecich, European Patent EP336014 (1989).

Google Scholar

[6] D. Avnir, S. Braun, O. Lev and M. Ottolenghi: Chem. Mater. Vol. 6 (1994), p.1605.

Google Scholar

[7] I. Gill and A. Ballesteros: TIBTECH Vol. 18 (2000), p.282.

Google Scholar

[8] I. Gill: Chem. Mater. Vol. 13 (2001), p.3404.

Google Scholar

[9] J. Livage, T. Choradin and C. Roux: J. Phys. Condens. Matter Vol. 13 (2001), p. R673.

Google Scholar

[10] H. Böttcher and K-H. Kallies, German Patent DE4416001 (1997).

Google Scholar

[11] P. Ducheyne, S. Radin and E.M. Santos, U.S. Patent 5, 591, 453. (1997).

Google Scholar

[12] M. Vallet-Regí, F. Balas and D. Arcos: Angew. Chem. Int. Ed. Vol. 46 (2007), p.7548.

DOI: 10.1002/anie.200604488

Google Scholar

[13] M. Ahola, H. Fagerholm, I. Kangasniemi, J. Kiesvaara, P. Kortesuo, K. Kurkela, N. Saarinen and A. Yli-Urpo, PCT Publication WO97/45367 (1997).

Google Scholar

[14] M. Jokinen, R. Viitala and H. Jalonen, PCT Publication WO2005/082781 (2005).

Google Scholar

[15] R. Viitala, M. Jokinen, S. Tuusa, J.B. Rosenholm and H. Jalonen: J. Sol-Gel Sci. Tech. Vol. 36 (2005), p.147.

DOI: 10.1007/s10971-005-5286-1

Google Scholar

[16] R. Viitala, M. Jokinen, S-L. Maunu, H. Jalonen, J.B. Rosenholm: J. Non-Cryst. Sol. Vol. 351 (2005), p.3225.

DOI: 10.1016/j.jnoncrysol.2005.08.023

Google Scholar

[17] R. Viitala, M. Jokinen and J.B. Rosenholm: Int. J. Pharm. Vol. 336 (2007), p.382.

Google Scholar

[18] T. Choradin, M. Boissiere and J. Livage: Current Med. Chem. Vol 13 (2006), p.99.

Google Scholar

[19] M. Koskinen, E. Säilynoja, M. Ahola, H. Jalonen, J. Salonen and V-M. Kähäri, PCT Publication WO02/80977 (2002).

Google Scholar

[20] M. Koskinen, M. Toriseva, M. Jokinen, H. Jalonen, J. Salonen, and V-M. Kähäri: Molecular Therapy Vol. 11, Suppl. 1 (2005), p. S422.

Google Scholar

[21] M. Jokinen, M. Koskinen and H. Jalonen, International Patent Application PCT/FI2007/000136 (2007).

Google Scholar

[22] T. Choradin and J. Livage: Acc. Chem. Res., Vol. 40 (9) (2007), p.819.

Google Scholar

[23] D-M. Liu and I-W. Chen, U.S. Patent 6, 303, 290 (2001).

Google Scholar

[24] M-L. Ferrer, L. Yuste, F. Rojo and F. del Monte: Chem. Mater Vol. 15 (2003), p.3614.

Google Scholar

[25] C.J. Brinker and G.W. Scherer: Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing (Academic Press, Inc. 1990).

Google Scholar

[26] W. Lai, J. Carino and P. Ducheyne: Biomaterials Vol. 23 (2002), p.213.

Google Scholar

[27] R.K. Iler: The Chemistry of Silica: Solubility, Polymerization, Colloid and Surface Properties, and Biochemistry (John Wiley & Sons, Inc. 1979).

Google Scholar

[28] P. Kortesuo, M. Ahola P. Kortesuo, M. Ahola, S. Karlsson, I. Kangasniemi, A. Yli-Urpo and J. Kiesvaara: Biomaterials Vol. 21 (2000), p.193.

DOI: 10.1016/s0142-9612(99)00148-9

Google Scholar

[29] P. Kortesuo, M. Ahola, S. Karlsson, I. Kangasniemi, J. Kiesvaara and A. Yli-Urpo: J. Biomed. Mat. Res. Vol. 44 (1999), p.162.

DOI: 10.1002/(sici)1097-4636(199902)44:2<162::aid-jbm6>3.0.co;2-p

Google Scholar

[30] Seventeenth Report of the Joint FAO/WHO Expert Committee on Food Additives, Wld Hlth Org. Techn. Rep. Ser., No. 539 (1974).

Google Scholar

[31] L.L. Hench and J.M. Polak: Science Vol. 295 (2002), p.1014.

Google Scholar

[32] M. Jokinen, T. Peltola, S. Veittola, M. Ahola, P. Kortesuo, PCT Publication WO00150345 (2000).

Google Scholar

[33] T. Peltola, M. Jokinen, S. Veittola, A. Yli-Urpo, PCT Publication WO01/40556 (2001).

Google Scholar

[34] M. Jokinen, T. Peltola, S. Veittola, H. Rahiala and J.B. Rosenholm: J. Eur. Cer. Soc. Vol. 20(11) (2000), p.1739.

Google Scholar

[35] T. Peltola, M. Jokinen, S. Veittola, H. Rahiala and A. Yli-Urpo: Biomaterials Vol. 22(6) (2001), p.589.

DOI: 10.1016/s0142-9612(00)00219-2

Google Scholar

[36] T. Peltola, M. Jokinen, S. Veittola, J. Simola and A. Yli-Urpo: J. Biomed. Mat. Res. Vol. 54 (2001), p.579.

DOI: 10.1002/1097-4636(20010315)54:4<579::aid-jbm150>3.0.co;2-q

Google Scholar

[37] B.V. Derjaguin and L.D. Landau , Acta Physicochim., U.S.S.R., Vol. 14 (1941). P. 633.

Google Scholar

[38] E.J.W. Verwey and Th.G. Overbeek , Theory of the Stability of Lyophobic Colloids (Elsevier, 1948).

Google Scholar

[39] M-A. Einarsrud: J. Non-Cryst. Solids Vol. 225 (1998), p.1.

Google Scholar